publications
THEIA™ development, and testing of artificial intelligence‐based primary triage of diabetic retinopathy screening images in New Zealand
- In Publication
Prospective Study
-
712 patients
-
100% Imageability
-
94.2% Sensitivity
-
96.0% Specificity
THEIA development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand
- In Publication